|
1.
|
Gray-Schopfer V, Wellbrock C and Marais R:
Melanoma biology and new targeted therapy. Nature. 445:851–857.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Verhoeven DT, Goldbohm RA, van Poppel G,
Verhagen H and van den Brandt PA: Epidemiological studies on
brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers
Prev. 5:733–748. 1996.PubMed/NCBI
|
|
3.
|
Zhang SM, Hunter DJ, Rosner BA,
Giovannucci EL, Colditz GA, Speizer FE and Willett WC: Intakes of
fruits, vegetables, and related nutrients and the risk of
non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers
Prev. 9:477–485. 2000.
|
|
4.
|
Bedikian AY, Millward M, Pehamberger H,
Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey
P, Kirkwood JM and Haluska FG: Bcl-2 antisense (oblimersen sodium)
plus dacarbazine in patients with advanced melanoma: the Oblimersen
Melanoma Study Group. J Clin Oncol. 24:4738–4745. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Musonda CA and Chipman JK: Quercetin
inhibits hydrogen peroxide (H2O2)-induced
NF-kappaB DNA binding activity and DNA damage in HepG2 cells.
Carcinogenesis. 19:1583–1589. 1998.PubMed/NCBI
|
|
6.
|
Avila MA, Velasco JA, Cansado J and
Notario V: Quercetin mediates the down-regulation of mutant p53 in
the human breast cancer cell line MDA-MB468. Cancer Res.
54:2424–2428. 1994.PubMed/NCBI
|
|
7.
|
Vijayababu MR, Arunkumar A, Kanagaraj P,
Venkataraman P, Krishnamoorthy G and Arunakaran J: Quercetin
downregulates matrix metalloproteinases 2 and 9 proteins expression
in prostate cancer cells (PC-3). Mol Cell Biochem. 287:109–116.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Choi S and Singh SV: Bax and Bak are
required for apoptosis induction by sulforaphane, a cruciferous
vegetable-derived cancer chemopreventive agent. Cancer Res.
65:2035–2043. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Zhang Y, Tang L and Gonzalez V: Selected
isothiocyanates rapidly induce growth inhibition of cancer cells.
Mol Cancer Ther. 2:1045–1052. 2003.PubMed/NCBI
|
|
10.
|
Zhang W and Zhang F: Effects of quercetin
on proliferation, apoptosis, adhesion and migration, and invasion
of HeLa cells. Eur J Gynaecol Oncol. 30:60–64. 2009.PubMed/NCBI
|
|
11.
|
Braganhol E, Zamin LL, Canedo AD, Horn F,
Tamajusuku AS, Wink MR, Salbego C and Battastini AM:
Antiproliferative effect of quercetin in the human U138MG glioma
cell line. Anticancer Drugs. 17:663–671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Dashwood RH and Ho E: Dietary histone
deacetylase inhibitors: from cells to mice to man. Semin Cancer
Biol. 17:363–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Juge N, Mithen RF and Traka M: Molecular
basis for chemoprevention by sulforaphane: a comprehensive review.
Cell Mol Life Sci. 64:1105–1127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Singh AV, Xiao D, Lew KL, Dhir R and Singh
SV: Sulforaphane induces caspase-mediated apoptosis in cultured
PC-3 human prostate cancer cells and retards growth of PC-3
xenografts in vivo. Carcinogenesis. 25:83–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Myzak MC, Tong P, Dashwood WM, Dashwood RH
and Ho E: Sulforaphane retards the growth of human PC-3 xenografts
and inhibits HDAC activity in human subjects. Exp Biol Med.
232:227–234. 2007.PubMed/NCBI
|
|
16.
|
Thejass P and Kuttan G: Antimetastatic
activity of sulforaphane. Life Sci. 78:3043–3050. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Parks WC, Wilson CL and Lopez-Boado YS:
Matrix metalloproteinases as modulators of inflammation and innate
immunity. Nat Rev Immunol. 4:617–629. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Shapiro SD: Matrix metalloproteinase
degradation of extracellular matrix: biological consequences. Curr
Opin Cell Biol. 10:602–608. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Pyke C, Ralfkiaer E, Tryggvason K and Dano
K: Messenger RNA for two type IV collagenases is located in stromal
cells in human colon cancer. Am J Pathol. 142:359–365.
1993.PubMed/NCBI
|
|
20.
|
Zeng ZS and Guillem JG: Colocalisation of
matrix metalloproteinase-9-mRNA and protein in human colorectal
cancer stromal cells. Br J Cancer. 74:1161–1167. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Houde M, de Bruyne G, Bracke M,
Ingelman-Sundberg M, Skoglund G, Masure S, van Damme J and
Opdenakker G: Differential regulation of gelatinase B and
tissue-type plasminogen activator expression in human Bowes
melanoma cells. Int J Cancer. 53:395–400. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Rangaswami H, Bulbule A and Kundu GC:
Nuclear factor inducing kinase plays crucial role in osteopontin
induced MAPK/IKK dependent nuclear factor κB-mediated promatrix
metalloproteinase-9 activation. J Biol Chem. 279:38921–38935.
2004.PubMed/NCBI
|
|
23.
|
Coussens LM, Tinkle CL, Hanahan D and Werb
Z: MMP-9 supplied by bone marrow-derived cells contributes to skin
carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Muroski ME, Roycik MD, Newcomer RG, van
den Steen PE, Opdenakker G, Monroe HR, Sahab ZJ and Sang QX: Matrix
metalloproteinase-9/gelatinase B is a putative therapeutic target
of chronic obstructive pulmonary disease and multiple sclerosis.
Curr Pharm Biotechnol. 9:34–46. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Ram M, Sherer Y and Shoenfeld Y: Matrix
metalloproteinase-9 and autoimmune diseases. J Clin Immunol.
26:299–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Xiao D, Choi S, Johnson DE, Vogel VG,
Johnson CS, Trump DL, Lee YJ and Singh SV: Diallyl
trisulfide-induced apoptosis in human prostate cancer cells
involves c-Jun N-terminal kinase and extracellular-signal regulated
kinase-mediated phosphorylation of Bcl-2. Oncogene. 23:5594–5606.
2004. View Article : Google Scholar
|
|
27.
|
Behera R, Kumar V, Lohite K, Karnik S and
Kundu GC: Activation of JAK2/STAT3 signaling by osteopontin
promotes tumor growth in human breast cancer cells. Carcinogenesis.
31:192–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Philip S, Bulbule A and Kundu GC:
Osteopontin stimulates tumor growth and activation of promatrix
metalloproteinase-2 through nuclear factor-kappa B-mediated
induction of membrane type 1 matrix metalloproteinase in murine
melanoma cells. J Biol Chem. 276:44926–44935. 2001. View Article : Google Scholar
|
|
29.
|
Chakraborty G, Jain S and Kundu GC:
Osteopontin promotes vascular endothelial growth factor-dependent
breast tumor growth and angiogenesis via autocrine and paracrine
mechanisms. Cancer Res. 68:152–161. 2008. View Article : Google Scholar
|
|
30.
|
Jain S, Chakraborty G and Kundu GC: The
crucial role of cyclooxygenase-2 in osteopontin-induced protein
kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate
tumor progression and angiogenesis. Cancer Res. 66:6638–6648. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Philip S and Kundu GC: Osteopontin induces
nuclear factor kappa B-mediated promatrix metalloproteinase-2
activation through I kappa B alpha /IKK signaling pathways, and
curcumin (diferulolylmethane) down-regulates these pathways. J Biol
Chem. 278:14487–14497. 2003. View Article : Google Scholar
|
|
32.
|
Jeong JH, An JY, Kwon YT, Rhee JG and Lee
YJ: Effects of low dose quercetin: cancer cell-specific inhibition
of cell cycle progression. J Cell Biochem. 106:73–82. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Aggarwal BB and Shishodia S: Molecular
targets of dietary agents for prevention and therapy of cancer.
Biochem Pharmacol. 71:1397–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008.PubMed/NCBI
|
|
35.
|
Zhang X-M, Huang S-P and Xu Q: Quercetin
inhibits the invasion of murine melanoma B16BL6 cells by decreasing
pro-MMP-9 via the PKC pathway. Cancer Chemother Pharmacol.
53:82–88. 2004. View Article : Google Scholar : PubMed/NCBI
|
